News & Publications
Stanford Cancer Institute News
-
Navigating Cancer Care With a Disability
Navigating cancer care can be overwhelming, but when combined with a disability, it becomes even more complex. Concerns about accommodations, potential dismissals, or changes to treatment options may arise.
-
Happy Clinical Trials Day: Reflections from the Stanford Cancer Institute’s Cancer Clinical Trials Office
The Stanford Cancer Institute’s Cancer Clinical Trials office (SCI-CCTO) celebrated Clinical Trials Day on May 18, 2023.
-
Patel Named Advocacy Champion by the American Society of Clinical Oncology
ASCO recognized SCI member Manali Patel as an Advocacy Champion due to her efforts in ensuring equitable, high-quality cancer care for all.
-
Immunotherapy and cell therapy expand treatment possibilities for melanoma patients
To learn more about current melanoma treatment and advances in treatment, we talked with SCI member Allison Betof Warner, MD, PhD, leader of Stanford’s Melanoma & Cutaneous Oncology Clinical Research Group.
Stanford Medicine News: Cancer
-
Personalized PSA levels could improve prostate cancer screening
The solution to the overdiagnosis and overtreatment of prostate cancer could lie in every man’s genome. Stanford Medicine researchers take a step toward genetically personalized cancer screening.
-
Genes linked to familial brain cancer identified in Stanford Medicine-led study
An international effort led by a Stanford Medicine researcher finds more than 50 genes linked to glioma — a rare brain cancer. Although most gliomas are sporadic, a minority are inherited.
-
Video distraction helps kids undergo cancer radiotherapy, Stanford Medicine-led study finds
Most children receiving radiation therapy for cancer can hold still without anesthesia if they watch videos during the treatment, a study of a technique developed at Stanford Medicine found.
-
Antibiotics after breast cancer linked to poorer survival, Stanford Medicine-led study finds
Triple-negative breast cancer patients who used antibiotics within three years of diagnosis have an increased risk of death, according to a study. The gut microbiome is a likely link.
Scope Blog
Stanford University News: Cancer
Stanford engineers develop new wearable device to monitor tumor size
Stanford engineers develop new wearable device to monitor tumor size
Lorry I. Lokey, alum and philanthropist who transformed Stanford, dies at 95
Lorry I. Lokey, ’49, a self-made media titan who founded Business Wire and pledged his wealth to Stanford and other philanthropic causes, died on Oct. 1. He was 95.
Stanford scientists develop new method to faster – and more accurately – find antigens that trigger specific immune cells
Their approach, which mimics the physical forces exerted by immune cells as they crawl over host cells, could help scientists develop more effective cancer immunotherapies.
Media Relations
The Office of Communication & Public Affairs is dedicated to sharing School of Medicine news with the media and helping journalists secure expert interviews, photographs and rich media for stories on medicine and health care.